AKI |
acute kidney injury |
ARC |
augmented renal clearance |
AUC |
area under the concentration time curve |
BLBLI |
β-lactam/β-lactamase inhibitors |
BLI |
β-lactamase inhibitors |
BMI |
body mass index |
CAZ/AVI |
ceftazidime/avibactam |
CFR |
cumulative fraction of response |
CFU |
colony-forming units |
C.I |
continuous infusion |
CL |
clearance |
Cmax |
maximum concentration |
Cmin |
minimal concentration |
CrCL |
creatinine clearance |
CRRT |
continuous renal replacement therapy |
CT |
threshold of concentration |
C/T |
ceftolozane/tazobactam |
CVVH |
continuous venovenous hemofiltration |
CVVHD |
continuous venovenous hemodialysis |
CVVHDF |
continuous venovenous hemodiafiltration |
ECMO |
extracorporeal membrane oxygenation |
E.I |
extended infusion |
g |
gram |
h |
hour |
ICUs |
intensive care units |
IMI/REL |
imipenem/relebactam |
LD |
loading dose |
MDR |
multidrug-resistant |
MEV |
meropenem/vaborbactam |
MIC |
minimum inhibitory concentration |
MRSE |
methicillin-resistant S. epidermidis
|
PICO |
population, intervention, comparator, outcome |
PIRRT |
prolonged intermittent renal replacement therapy |
PK/PD |
pharmacokinetic/pharmacodynamic |
PsA |
Pseudomonas aeruginosa |
PTA |
probability of target attainment |
Qxh |
every x hours |
RRT |
renal replacement therapy |
TDM |
therapeutic drug monitoring |
VA-ECMO |
venoarterial ECMO |
Vd |
volume of distribution |
VV-ECMO |
venovenous ECMO |
%ƒT > MIC |
percentage of free drug concentration above MIC |